Ricardo P. Baptista

Chief Technology Officer • Alder Therapeutics AB

Ricardo Baptista has been working in Cell therapy Development globally, managing CMC teams on designing bioprocessing and analytical platforms for the scalable manufacture of allogeneic cell therapies in companies such as Procella Tx, Cellectis, CGT Catapult and CCRM. He was also involved in the generation and manufacture of clinical-grade iPSC lines, and in the design and construction of cleanroom facilities for CGT manufacturing according to GMP. Ricardo is a Biotechnology Engineer, who obtained his PhD degree in Biotechnology and Biochemical Engineering at Instituto Superior Tecnico, Portugal, and post-doctoral studies at Peter Zandstra’s Stem Cell Bioengineering Lab. 

Also speaking

Avencia Sanchez-Mejias

Co-Founder and Chief Executive Officer • Integra Therapeutics

Malik Kaman

Partner • ZS Consulting

Rui A. Sousa

Chief Executive Officer & Chairman • Stemmatters

Event Info


Innovation Zone

Find out more about the Innovation Zone at Advanced Therapies Europe.

Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.